Home
Obi Profile
Fees
Services
News
Publications
Contact
You are here:
Title Details
Search
Login
BARDOXOLONE METHYL FOR THE TREATMENT OF OBESITY
No-Receipt date
2020-00061 - 08/01/2020
No-Filing date
20200400055 - 08/01/2020
No-Granting date
3102425 - 31/01/2020
No-EPO application date
11715645.5 - 12/04/2011
No-EPO granting date
2558105 - 20/11/2019
Gazette No-Publication date of application
-
Gazette No-Publication date of granted patent
1/2020 - 18/03/2020
Expiration date
13/04/2031
Kind of title
Validation of European Patent
Legal status
VALID
Priorities
US389090 P01/10/2010/US
US323276 P12/04/2010/US
Active Substance of Supplementary Certificates
-
IPC Classification
Ipc Class
A61P 3/04
A61K 31/275
Related Documents
Related Titles
Owners
Code
Firstname
Surname
Address
Town
ZIP
Country
1639348
REATA PHARMACEUTICALS HOLDINGS, LLC
5320 LEGACY DRIVE, PLANO
TEXAS, U.S.A.
75024
UNITED STATES OF AMERICA (USA)
Inventors
Code
Firstname
Surname
2838063
MEYER, COLIN, J.
2838064
HUFF, WARREN
Representatives
Code
Firstname
Surname
Address
Town
Zip
3178
STEFANOS ALEXIOS
TSIMIKALIS "TSIMIKALIS KALONAROU DIKIGORIKI ETAIREIA"
NEOFYTOU VAMVA 1
ATHINA (ATTIKIS)
10674
Contact
Code
Firstname
Surname
Address
Town
Zip
Country
8126
STEFANOS ALEXIOS
TSIMIKALIS
NEOFYTOU VAMVA 1
ATHINA (ATTIKIS)
10674
GREECE
Owners History
Date
Description
Comments
Data before modification
Data after modification
08/04/2024
Μεταβίβαση (7e802)
ΑΡ.ΠΡΩΤ. 8486/2024 (ΑΡ.ΥΠΟΘ. 4851047/2024) ΠΛΗΡΕΞ. ΔΙΚΗΓΟΡΟΣ ΣΤΕΦΑΝΟΣ ΤΣΙΜΙΚΑΛΗΣ (ΜΕΤΑΒΙΒΑΣΗ)
1121448 Reata Pharmaceuticals, Inc. 2801 Gateway Drive, Suite 150 ΗΝΩΜΕΝΕΣ ΠΟΛΙΤΕΙΕΣ ΤΗΣ ΑΜΕΡΙΚΗΣ Irving, TX 75063-2648
1639348 Reata Pharmaceuticals Holdings, LLC 5320 Legacy Drive, Plano ΗΝΩΜΕΝΕΣ ΠΟΛΙΤΕΙΕΣ ΤΗΣ ΑΜΕΡΙΚΗΣ TEXAS, U.S.A.
Title Instruments
Payments history
15 renewals have been done
© OBI all rights reserved
designed & developed by PROFILE S.A.
Certified QMS :
EN ISO 9001:2015
and
ΕΝ ISO 14001:2015
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).